#EYEPOINT - Twitter Hashtag

PharmaShots | Iluminate.Innovate.Inspire

4 days ago

EyePoint reported that Duravyu missed the primary endpoint in its Phase III LUCIA trial for wet AMD but achieved key secondary endpoints, including a 38% reduction in treatment burden. The company will analyze the data to determine next steps. #eyepoint #duravyu #lucia #pharmashots https://t.co/veV5viMmav

1

0

59

insider trading

@insider_daily

2 months ago

🟢 Karen L. Zaderej, Director of EyePoint just bought $52K of $EYPT 10,600 shares at $4.93 · Now holds 49,100 shares Aug 18 · SEC Form 4 🔗 https://t.co/jg3Dasbiko #InsiderTrading #EyePoint #Stocks #Trading

insider_daily's tweet photo. 🟢 Karen L. Zaderej, Director of EyePoint just bought $52K of $EYPT

10,600 shares at $4.93 · Now holds 49,100 shares

Aug 18 · SEC Form 4
🔗 https://t.co/jg3Dasbiko
#InsiderTrading #EyePoint #Stocks #Trading https://t.co/vhUSTSwNCe

0

3

0

322

Business-News-Today.com

@BNTBriefing

3 months ago

DURAVYU pivotal trials move closer to testing a longer-lasting diabetic eye treatment https://t.co/vEhUyLkvh6 $EYPT #EyePoint #DURAVYU #DiabeticMacularEdema #DME #Retina #ClinicalTrials #Ophthalmology

0

2

0

258

EyePoint

@EyePointPharma

about 1 year ago

Team #EyePoint is presenting this month at the @EURETINA Innovation Spotlight and Congress, currently taking place, and at the @RetinaSociety Annual Meeting, occurring next week. Attending? Don't miss key information on our lead pipeline candidate in #WetAMD and #DME, including: 🔍 Data on treatment burden and the full results from our DAVIO 2 trial in wet AMD 📄 Design of our pivotal Phase 3 LUGANO and LUCIA trials 📊 Results from our Phase 2 VERONA trial in DME

EyePointPharma's tweet photo. Team #EyePoint is presenting this month at the @EURETINA Innovation Spotlight and Congress, currently taking place, and at the @RetinaSociety Annual Meeting, occurring next week.

Attending? Don't miss key information on our lead pipeline candidate in #WetAMD and #DME, including:

🔍 Data on treatment burden and the full results from our DAVIO 2 trial in wet AMD
📄 Design of our pivotal Phase 3 LUGANO and LUCIA trials
📊 Results from our Phase 2 VERONA trial in DME

1

2

0

135

ET NOW

@ETNOWlive

over 2 years ago

US Markets At Open | S&P 500, Nasdaq 100 open flat; these are the other highlights👇 @Nasdaq #Eyepoint #Freshpet

0

6

1

2K

11th.com

@11thestate

almost 3 years ago

~ In Aug 2022, #EyePoint received a subpoena from the Attorney's Office for the District of Massachusetts. ~ $EYPT fell 10%, losing $56M+ shareholder value. ~ Investors may have grounds to suspect #EYPT of hiding regulatory issues => https://t.co/GAwcGnssxW

0

4

0

88

EyePoint

@EyePointPharma

about 5 years ago

#EyePoint appreciates the opportunity to support #ASRS2021 in San Antonio. It was great connecting live with everyone and we’re grateful to those who made time to speak with us. #ASRS #retina #uveitis #OphthoTwitter $EYPT

EyePointPharma's tweet photo. #EyePoint appreciates the opportunity to support #ASRS2021 in San Antonio.

It was great connecting live with everyone and we’re grateful to those who made time to speak with us.
#ASRS #retina #uveitis #OphthoTwitter $EYPT https://t.co/H8Nm3q5nBs

0

6

0

Wildbroker @wildbroker

almost 6 years ago

#eyepoint pues seguimos por ahora la fiesta. A ver como acaba el dia parece que esta contenta.😉

Wildbroker @wildbroker

almost 6 years ago

#eyepoint +10% estoy deseando verla mañana

0

2

0

1

0

Wildbroker @wildbroker

almost 6 years ago

#eyepoint +10% estoy deseando verla mañana

Wildbroker @wildbroker

almost 6 years ago

#eyepoint otro valor que me puso ojitos. Indicadores poco favorables pero muy castigados y si le entra volumen puede romper la bajista y suele dar multiplicadores interesantes. Está en RCP pero como desfibrile bien...:-)

0

2

0

2

0

Wildbroker @wildbroker

almost 6 years ago

#eyepoint otro valor que me puso ojitos. Indicadores poco favorables pero muy castigados y si le entra volumen puede romper la bajista y suele dar multiplicadores interesantes. Está en RCP pero como desfibrile bien...:-)

0

2

0

9trading Stocks @9TradingDotCom

about 6 years ago

#EyePoint Pharmaceuticals Inc. ( $EYPT) Soaring with heavy volume. Buy rating: 6.5. https://t.co/24VOmIgDWj

0

2

0

Preticks @preticks

about 6 years ago

Latest headline: $EYPT: EyePoint Pharmaceuticals Receives $9.5 Million in Upfront Cash from Ocumension Therapeutics Under Expanded License Agreements https://t.co/uvmtlPpH1Y #stockstowatch #premarket #DayTrading #NASDAQ #EyePoint

0

2

0